atazanavir sulfate has been researched along with sodium ethylxanthate in 1 studies
| Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (sodium ethylxanthate) | Trials (sodium ethylxanthate) | Recent Studies (post-2010) (sodium ethylxanthate) |
|---|---|---|---|---|---|
| 1,102 | 246 | 590 | 7,743 | 58 | 361 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babacan, E; Carlebach, A; Haberl, A; Harder, S; Knecht, G; Lennemann, T; Staszewski, S; von Hentig, N | 1 |
1 other study(ies) available for atazanavir sulfate and sodium ethylxanthate
| Article | Year |
|---|---|
The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors.
Topics: Adult; Area Under Curve; Atazanavir Sulfate; Chromatography, High Pressure Liquid; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Metabolic Clearance Rate; Middle Aged; Oligopeptides; Outpatients; Plasma; Pyridines; Ritonavir; Sex; Tandem Mass Spectrometry | 2008 |